7 results
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
Women with in HIV-AIDS ... #HumanPapillomavirus ... #Treatment #management ... #opportunistic ... #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
Candidiasis in HIV-AIDS ... 21 days) Note: Systemic ... #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
IDSA Recommendations ... in HIV-AIDS Preventing ... Prevention #Treatment #management ... #opportunistic ... #pharmacology
Immune Reconstitution Inflammatory Syndrome - Overview of IRIS

What Is IRIS?
	• A state of hyperinflammatory response that
/AIDS patients ... reconstituted immune system ... opportunistic infection ... be present: • AIDS ... #Diagnosis #Management
Candida Glabrata
Species of Candida Most Commonly Isolated in Bloodstream Infections
 • Symptomatic mucosal infection is detected
candidiasis, in HIV ... /AIDS & other immune-compromised ... Dissemination to organ systems ... CGlabrata #candidemia #diagnosis ... #management #infectiousdiseases
IDSA Recommendations for Preventing and Treating Varicella Zoster Virus (VZV) Infections in HIV-AIDS
Pre-Exposure Prevention of VZV
in HIV-AIDS Pre-Exposure ... health-care provider diagnosis ... Prevention #Treatment #management ... #opportunistic ... #pharmacology
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
and Disease in HIV-AIDS ... and molecular diagnostic ... Prevention #Treatment #management ... #opportunistic ... #pharmacology